Castle Biosciences, Inc. - Common stock (CSTL) Covered Calls

You can sell covered calls on Castle Biosciences, Inc. - Common stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CSTL (prices last updated Mon 10:20 AM ET):

Castle Biosciences, Inc. - Common stock (CSTL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
20.68 +0.34 20.55 20.77 6K - 0.6
Covered Calls For Castle Biosciences, Inc. - Common stock (CSTL)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 20 1.45 19.32 3.5% 67.2%
Jun 21 20 2.35 18.42 8.6% 58.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Castle Biosciences, Inc., a commercial-stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify stage I and II patients at high risk of metastasis based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products in development, which address cutaneous squamous cell carcinoma and suspicious pigmented lesions, which are indications with high clinical need in dermatological cancer. It offers test services through physicians, physician assistants, and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.